{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:18Z","timestamp":1792276278373,"version":"4.4.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ens-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eNeurologicalSci"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ensci.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T01:00:13Z","timestamp":1501808413000},"page":"40-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Cefepime induced neurotoxicity: A case series and review of the literature"],"prefix":"10.1016","volume":"8","author":[{"given":"Cigdem","family":"Isitan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ferree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna DePold","family":"Hohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ensci.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0987-7053(00)00234-3","article-title":"Severe but reversible encephalopathy associated with cefepime","volume":"30","author":"Jallon","year":"2000","journal-title":"Neurophysiol. Clin."},{"issue":"3","key":"10.1016\/j.ensci.2017.08.001_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1592\/phco.23.3.369.32100","article-title":"Retrospective review of neurotoxicity induced by cefepime and ceftazidime","volume":"23","author":"Chow","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.ensci.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3109\/00365548.2011.581308","article-title":"Cefepime neurotoxicity despite renal adjusted dosing","volume":"43","author":"Gangireddy","year":"2011","journal-title":"Scand. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ensci.2017.08.001_bb0020","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/cc13094","article-title":"Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy","volume":"17","author":"Fugate","year":"2013","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.ensci.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11096-013-9799-3","article-title":"Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem","volume":"35","author":"Tanaka","year":"2013","journal-title":"Int. J. Clin. Pharm."},{"issue":"10","key":"10.1016\/j.ensci.2017.08.001_bb0030","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","article-title":"High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function","volume":"54","author":"Lamoth","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ensci.2017.08.001_bb0035","unstructured":"FDA's Adverse Event Reporting System (AERS) database, from the date of approval of cefepime in 1996 through February 2012."}],"container-title":["eNeurologicalSci"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650217300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405650217300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T19:24:38Z","timestamp":1535570678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405650217300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":7,"alternative-id":["S2405650217300291"],"URL":"https:\/\/doi.org\/10.1016\/j.ensci.2017.08.001","relation":{},"ISSN":["2405-6502"],"issn-type":[{"value":"2405-6502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefepime induced neurotoxicity: A case series and review of the literature","name":"articletitle","label":"Article Title"},{"value":"eNeurologicalSci","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ensci.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}